About RMC Medical Research Ltd

RMC Medical Research Ltd has undertaken a variety of trials including influenza, diabetes, hypertension, chronic obstructive pulmonary disease (COPD). Topical non-steroidal anti-inflammatories, point-of-care investigation and asthma.

An independent company RMC Medical Research is led by two highly experienced medical professionals,
Dr. James Reid & Dr. Dean Millar-Coote - they have more than 30 years combined clinical trial experience. They are assisted by a Good Clinical Practice trained team with indepth expertise.

RMC specialises in clinical medical studies phases 2, 3 & 4 and has completed contracts for organisations in New Zealand and worldwide.

RMC is ideally located in Dunedin, New Zealand. Fortuitously, Dunedin has a population base of over 25,000 students also provides a significant and enthusiastic pool of eligible study participants.

RMC Medical Research Ltd has an extensive background of clinical medical research projects.

  • 2009 - CSL (Confidential)
  • 2008 - Boehringer Ingleheim (3x) Confidential
  • 2008 - BioCryst (Confidential)
  • 2008 - CSL (Confidential)
  • 2006 - GID 16 study sponsored by Sanofi Pasteur
  • 2001 - A randomized open controlled trial to assess safety and acceptability of 2001/2002 season intranasal influenza vaccination versus intramuscular influenza vaccination.
  • 1999 - A double blind randomized controlled efficacy and safety trial of HRM3647 (ketolide) versus oral amoxicillin in the treatment of community acquired pneumonia in adults.
  • 1997 - A double blind study to assess the efficiency of Relenza vaccine (NAIB 3001).


About Us

» Assoc. Prof. Jim Reid

MB, ChB, Dip.Obst (Otago), FRNZCGP (Dist), FCCP (USA), M.P.S. (NZ)

Current Employment
  • Partner, Caversham Medical Centre
Recent Clinical Studies Undertaken
  • 2008 - Boehringer Ingleheim (3x) Confidential
  • 2008 - BioCryst (Confidential)
  • 2008 - CSL (Confidential)
  • 2006 - GID 16 Sanafi Pasteur Monitored by Omni

» Dr. Dean Millar-Coote

MB, ChB (Otago), MRNZCGP, FRNZCGP, PGDipSpMed

Current Employment
  • Member, Southern Cancer Network
  • Partner, Caversham Medical Centre
Previous Appointments
  • Branch Medical Adviser, ACC Dunedin
  • Chair of South Link Health Inc. Ltd.
  • Chair of the Otago Family Health Team
  • Director, Unihealth Ltd
  • General Practitioner and IPA Representative Otago Diabetes Team
  • Sub-committee, Royal NZ College of GP's Quality
  • Member, Dunedin Faculty Royal NZ College of General Practitioners, Continuing Medical Education Committee.
Recent Clinical Studies Undertaken
  • 2008 - Boehringer (Confidential)
  • 2007/2008 - Boehringer (Confidential)
  • 2006 - GID 16 study sponsored by Sanofi Pasteur
  • 2001 - A randomized open controlled trial to assess safety and acceptability of 2001/2002 season intranasal influenza vaccination versus intramuscular influenza vaccination.
  • 1999 - A double blind randomized controlled efficacy and safety trial of HRM3647 (ketolide) versus oral amoxicillin in the treatment of community acquired pneumonia in adults.
  • 1997 - A double blind study to assess the efficiency of Relenza vaccine (NAIB 3001).

» Anne Connelly

Diploma of Practice Management
Certificate of Good Clinical Practice

Current Employment
  • Manager, RMC Medical Research Ltd
  • Study Co-ordinator, Clinical Trials
  • Practice Manager, Caversham Medical Centre
Duties and Responsiblities
  • Study Coordinator
  • Liaison with doctors, nurses, other staff and participants
  • Managing the financial accounts
  • Recruitment and training of staff
  • Maintaning database
  • Legislative requirements
  • She has an active role in the clinical trials as study co-coordinator and works with the clinical trial team to achieve a quality result


Key Staff

» Assoc. Prof. Jim Reid
» Dr. Dean Millar-Coote
» Anne Connelly


External Link

» RMC Medical Research Ltd has a close working association with Southern Clinical Trials.
www.sctrials.co.nz